The FDA has given approval to 23andMe, a private company, to
provide genetic testing directly to individuals. The results provide genetic risks of
contracting several medical conditions including Parkinson’s disease and
Alzheimer’s disease. No prescription or
physician visit is needed. While 23andMe
execs and marketers will undoubtedly claim that their mission is to empower the
public, this does not tell the whole story.
Indeed, many patients who undergo the testing will be worse for having
done so.
I would never submit to the 23andMe home testing program
myself, nor would I counsel my patients to do so. It seems bizarre that the incredibly complex
and nuanced medical issue of genetic risk would be available for direct
consumer purchase. We don’t permit
patients to order a chest x-ray on themselves, but yet we will give them access
to genetic testing results that many doctors like me won’t be able to
skillfully interpret. Make sense?
“How much risk can
there be if all you have do is to submit a saliva sample?”
The risks come later once the results are in. What is the value of discovering that you are
at risk of developing a disease when there is no available treatment that can
mitigate this risk? If you learn that
you have an increased risk of Alzheimer’s disease, would this knowledge improve
your health? Or would your life be filled
with worry over a possible agonizing future.
Would you wonder when you misplace your keys if the beginning of the end
is near? If you knew now that
Parkinson’s disease, an incurable and progressive neurologic disease, might be
percolating within your brain, would your life be better?
Importantly, having an increased genetic risk does not mean
that you will develop the condition. You
may very well live a long and happy life without ever developing the disease
that you are at risk for.
Of course, we should welcome genetic testing that can detect
risks of conditions that we can prevent or influence, an entirely different
issue from the one being discussed here.
Indeed, genetic testing has helped many of my patients and their
families.
Will the public be able to resist the pitch from 23andMe and
its competitors? While physicians can
educate our patients on the perils of these products, remember that patients
are free to purchase them themselves.
It is likely that we physicians will be called upon only after the confusing and ominous results
are in.
Finally, the genetic risk industry’s true mission may be to
sell genetic data to pharmaceutical companies and other institutions, a point
not emphasized to the public.
This comment has been removed by a blog administrator.
ReplyDelete